Hemispherian Competitors and Similar CompaniesClear all
Hemispherian's competitors and similar companies include Xencor, AstraZeneca, CyTuVax and Splash Pharmaceuticals.
 Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  CyTuVax CyTuVax is a company that develops therapeutic vaccines against cancer and protective vaccines against viral and bacterial pathogens. | |||
Founding Date | Founding Date 2015 | Founding Date 1997 | Founding Date 1999 | Founding Date 2012 | Founding Date 2001 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Oslo, NO HQ | Locations Pasadena, US HQ San Diego, US | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Maastricht, NL HQ | Locations San Diego, US HQ |
Employees | Employees 10 | Employees 2604% increase | Employees 94,300 | Employees N/A | Employees 1 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $125.6m (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($92.1m) (FY, 2025) | Net income $10.2b (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 7.4m (over 3 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 22.5m (over 17 years ago) |
Total funding raised | Total funding raised $ 9.8m | Total funding raised $ 108.4m | Total funding raised $ 1b | Total funding raised N/A | Total funding raised $ 23m |
For sources of this data, please see the company profile
View Company Profiles
Xencor
HQ
Pasadena, US
Employees
260↑ 4% increase
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyCyTuVax
HQ
Maastricht, NL
CyTuVax is a company that develops therapeutic vaccines against cancer and protective vaccines against viral and bacterial pathogens.
View company
Splash Pharmaceuticals
HQ
San Diego, US
Employees
1
Splash Pharmaceuticals is a cancer therapy company.
View company